Literature DB >> 27443928

Contemporary zebrafish transgenesis with Tol2 and application for Cre/lox recombination experiments.

A Felker1, C Mosimann1.   

Abstract

Spatiotemporal transgene regulation by transgenic DNA recombinases is a central tool for reverse genetics in multicellular organisms, with excellent applications for misexpression and lineage tracing experiments. One of the most widespread technologies for this purpose is Cre recombinase-controlled lox site recombination that is attracting increasing interest in the zebrafish field. Tol2-mediated zebrafish transgenesis provides a stable platform to integrate lox cassette transgenes, while the amenability of the zebrafish embryo to drug treatments makes the model an ideal candidate for tamoxifen-inducible CreERT2 experiments. In addition, advanced transgenesis technologies such as phiC31 or CRISPR-Cas9-based knock-ins are even further promoting zebrafish transgenesis for Cre/lox applications. In this chapter, we will first introduce the basics of Cre/lox methodology, CreERT2 regulation by tamoxifen, as well as the utility of Tol2 and other contemporary transgenesis techniques for Cre/lox experiments. We will then outline in detail practical experimental steps for efficient transgenesis toward the creation of single-insertion transgenes and will introduce protocols for 4-hydroxytamoxifen-mediated CreERT2 induction to perform spatiotemporal lox transgene regulation experiments in zebrafish embryos. Last, we will discuss advanced experimental applications of Cre/lox beyond traditional lineage tracing approaches.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cre/lox; Genetics; Genome engineering; Lineage tracing; Recombination; Tamoxifen; Tol2; Transgenesis; Zebrafish

Mesh:

Substances:

Year:  2016        PMID: 27443928     DOI: 10.1016/bs.mcb.2016.01.009

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  8 in total

1.  Continuous addition of progenitors forms the cardiac ventricle in zebrafish.

Authors:  Anastasia Felker; Karin D Prummel; Anne M Merks; Michaela Mickoleit; Eline C Brombacher; Jan Huisken; Daniela Panáková; Christian Mosimann
Journal:  Nat Commun       Date:  2018-05-21       Impact factor: 14.919

2.  Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish.

Authors:  Gianluca D'Agati; Elena María Cabello; Karl Frontzek; Elisabeth J Rushing; Robin Klemm; Mark D Robinson; Richard M White; Christian Mosimann; Alexa Burger
Journal:  Dis Model Mech       Date:  2019-07-16       Impact factor: 5.758

3.  Persistent Ventricle Partitioning in the Adult Zebrafish Heart.

Authors:  Catherine Pfefferli; Hannah R Moran; Anastasia Felker; Christian Mosimann; Anna Jaźwińska
Journal:  J Cardiovasc Dev Dis       Date:  2021-04-09

Review 4.  Zebrafish Models of Paediatric Brain Tumours.

Authors:  Faiza Basheer; Poshmaal Dhar; Rasika M Samarasinghe
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

5.  In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control.

Authors:  Anastasia Felker; Susan Nieuwenhuize; Aymeric Dolbois; Kristyna Blazkova; Christopher Hess; Larry W L Low; Sibylle Burger; Natasha Samson; Tom J Carney; Petr Bartunek; Cristina Nevado; Christian Mosimann
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

6.  Tbx5a lineage tracing shows cardiomyocyte plasticity during zebrafish heart regeneration.

Authors:  Héctor Sánchez-Iranzo; María Galardi-Castilla; Carolina Minguillón; Andrés Sanz-Morejón; Juan Manuel González-Rosa; Anastasia Felker; Alexander Ernst; Gabriela Guzmán-Martínez; Christian Mosimann; Nadia Mercader
Journal:  Nat Commun       Date:  2018-01-30       Impact factor: 14.919

7.  Bloody Zebrafish: Novel Methods in Normal and Malignant Hematopoiesis.

Authors:  Emma de Pater; Eirini Trompouki
Journal:  Front Cell Dev Biol       Date:  2018-10-15

Review 8.  Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future.

Authors:  Shuai Li; Kok Siong Yeo; Taylor M Levee; Cassie J Howe; Zuag Paj Her; Shizhen Zhu
Journal:  Cells       Date:  2021-03-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.